[1] |
GENOVESE C, LA FAUCI V, D'AMATO S, et al. Molecular epidemiology of antimicrobial resistant microorganisms in the 21th century: a review of the literature[J]. Acta Biomed,2020,91(2):256-273. |
[2] |
LEE CR, CHO IH, JEONG BC, et al. Strategies to minimize antibiotic resistance[J]. Int J Environ Res Public Health,2013,10(9):4274-305. doi: 10.3390/ijerph10094274 |
[3] |
HORSEMAN M A, SURANI S. A comprehensive review of Vibrio vulnificus: an important cause of severe Sepsis and skin and soft-tissue infection[J]. Int J Infect Dis,2011,15(3):e157-e166. doi: 10.1016/j.ijid.2010.11.003 |
[4] |
洪广亮, 卢才教, 赵光举, 等. 创伤弧菌脓毒症诊疗方案(2018)[J]. 中华急诊医学杂志, 2018, 27(6):594-598. |
[5] |
KIM H R, RHO H W, JEONG M H, et al. Hemolytic mechanism of cytolysin produced from V. vulnificus[J]. Life Sci,1993,53(7):571-577. doi: 10.1016/0024-3205(93)90714-E |
[6] |
LOS F C, RANDIS T M, AROIAN R V, et al. Role of pore-forming toxins in bacterial infectious diseases[J]. Microbiol Mol Biol Rev,2013,77(2):173-207. doi: 10.1128/MMBR.00052-12 |
[7] |
YUAN Y, FENG Z, WANG J. Vibrio vulnificus hemolysin: biological activity, regulation of vvhA expression, and role in pathogenesis[J]. Front Immunol,2020,11:599439. doi: 10.3389/fimmu.2020.599439 |
[8] |
QIN K W, FU K F, LIU J F, et al. Vibrio vulnificus cytolysin induces inflammatory responses in RAW264.7 macrophages through calcium signaling and causes inflammation in vivo[J]. Microb Pathog,2019,137:103789. doi: 10.1016/j.micpath.2019.103789 |
[9] |
HU C M J, FANG R H, COPP J, et al. A biomimetic nanosponge that absorbs pore-forming toxins[J]. Nat Nanotechnol,2013,8(5):336-340. doi: 10.1038/nnano.2013.54 |
[10] |
CAO H Q, DAN Z L, HE X Y, et al. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer[J]. ACS Nano,2016,10(8):7738-7748. doi: 10.1021/acsnano.6b03148 |
[11] |
HE Y W, LI R X, LI H C, et al. Erythroliposomes: integrated hybrid nanovesicles composed of erythrocyte membranes and artificial lipid membranes for pore-forming toxin clearance[J]. ACS Nano,2019,13(4):4148-4159. doi: 10.1021/acsnano.8b08964 |
[12] |
DAL PERARO M, VAN DER GOOT F G. Pore-forming toxins: ancient, but never really out of fashion[J]. Nat Rev Microbiol,2016,14(2):77-92. doi: 10.1038/nrmicro.2015.3 |
[13] |
QIN S G, XIAO W, ZHOU C M, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics[J]. Signal Transduct Target Ther,2022,7(1):199. doi: 10.1038/s41392-022-01056-1 |
[14] |
ALLEN R C, POPAT R, DIGGLE S P, et al. Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol,2014,12(4):300-308. doi: 10.1038/nrmicro3232 |
[15] |
BISCHOFBERGER M, IACOVACHE I, VAN DER GOOT F G. Pathogenic pore-forming proteins: function and host response[J]. Cell Host Microbe,2012,12(3):266-275. doi: 10.1016/j.chom.2012.08.005 |
[16] |
MOLINARO R, CORBO C, MARTINEZ J O, et al. Biomimetic proteolipid vesicles for targeting inflamed tissues[J]. Nat Mater,2016,15(9):1037-1046. doi: 10.1038/nmat4644 |
[17] |
KIM Y R, KIM B U, KIM S Y, et al. Outer membrane vesicles of Vibrio vulnificus deliver cytolysin-hemolysin VvhA into epithelial cells to induce cytotoxicity[J]. Biochem Biophys Res Commun,2010,399(4):607-612. doi: 10.1016/j.bbrc.2010.07.122 |